This approach is proven to increase patient acquisition for high-value service lines, like imaging and oncology

"We're grateful to be working with such a flexible payment structure where we can repay the investment through our future revenues." - Ben Bowman, CancerIQ CFO

HMH Partners with CancerIQ to Provide Screening and Early Detection-the key to Prevention and Improved outcomesHACKENSACK, N.J., Aug. 20, 2024 /PRNewswire/ -- Hackensack Meridian Health's (HMH) John Theurer Cancer Center today announces the launch of its cancer risk and early cancer detection program, designed to better identify the risk of cancer in individuals and enable earlier diagnosis.Hackensack Meridian Health’s new Hennessy Institute for Cancer Prevention and Applied Molecular Medicine rolls out a new cancer risk assessment.The new program is offered at HMH's Hennessy Institute for Cancer Prevention and Applied Molecular Medicine (HICAP) located at the recently established Cancer Center at Totowa on the St. Joseph's Health campus in Totowa, NJ, and will expand to its headquarters in our new ambulatory facility in Clifton, New Jersey near Hackensack Meridian's School of Medicine and Center for Discovery and Innovation in early 2025.The HMH network is the first in New Jersey to offer this comprehensive, early detection and cancer risk management, joining a few programs in the nation in the broader endeavor of conducting cancer screening at scale, and cancer interception. The venture is a partnership between HICAP and CancerIQ, a best-in-class cancer-focused precision health platform, to launch a groundbreaking new program that aims to improve access to inform cancer risk care, shift cancer diagnoses to earlier stages, and reduce cancer burden at scale.It is well established that earlier diagnosis translates into better outcomes. For example, the 5-year survival for cancers such as pancreatic and lung - typically diagnosed late - goes from 10-15% in advanced stage cancer to over 80-85% survival in early stage. In addition, roughly 10% of all cancers are hereditary with known genetic risk factors